Yüksel Ürün: Important information for lung cancer patients taking TKIs

Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School of Medicine, Turkey, shared a post on X:

“Important information for lung cancer patients taking TKIs (tyrosine kinase inhibitor)

Lung cancer patients taking both PPIs (proton pump inhibitor) and certain TKIs may have higher risk of death!
New study finds drug drug interaction reduces drug effectiveness.
Avoid unnecessary drug use!”